Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.41 USD | -0.70% | -10.76% | -46.59% |
Apr. 08 | Transcript : Cue Biopharma, Inc., Q4 2023 Earnings Call, Apr 08, 2024 | |
Apr. 08 | North American Morning Briefing : Inflation Data, -2- | DJ |
Financials (USD)
Sales 2024 * | 9.01M | Sales 2025 * | 15.73M | Capitalization | 68.59M |
---|---|---|---|---|---|
Net income 2024 * | -57M | Net income 2025 * | -68M | EV / Sales 2024 * | 7.62 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 4.36 x |
P/E ratio 2024 * |
-1.37
x | P/E ratio 2025 * |
-1.4
x | Employees | 53 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.03% |
Latest transcript on Cue Biopharma, Inc.
1 day | -0.70% | ||
1 week | -10.76% | ||
Current month | -25.40% | ||
1 month | -24.19% | ||
3 months | -47.78% | ||
6 months | -24.60% | ||
Current year | -46.59% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel Passeri
CEO | Chief Executive Officer | 63 | 16-07-31 |
Anish Suri
PSD | President | 50 | 18-06-30 |
Kerri-Ann Millar
DFI | Director of Finance/CFO | 54 | 17-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Fred Driscoll
BRD | Director/Board Member | 74 | 18-06-25 |
Daniel Passeri
CEO | Chief Executive Officer | 63 | 16-07-31 |
Peter Kiener
BRD | Director/Board Member | 72 | 16-02-29 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 2 M€ | -.--% | ||
0.00% | 34 M€ | +2.22% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 1.41 | -0.70% | 169,155 |
24-04-24 | 1.42 | -5.33% | 319,520 |
24-04-23 | 1.5 | -4.46% | 161,467 |
24-04-22 | 1.57 | +0.64% | 181,253 |
24-04-19 | 1.56 | -1.27% | 169,010 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-46.59% | 68.59M | |
-2.26% | 103B | |
+1.41% | 95.71B | |
+0.61% | 22.02B | |
-17.84% | 20.9B | |
-8.96% | 17.85B | |
-42.83% | 16.21B | |
-17.63% | 15.52B | |
+4.55% | 13.86B | |
+32.11% | 12.04B |
- Stock Market
- Equities
- CUE Stock